BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37873333)

  • 1. Methylphenidate alleviates cognitive dysfunction from early Mn exposure: Role of catecholaminergic receptors.
    Beaudin SA; Howard S; Santiago N; Strupp BJ; Smith DR
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylphenidate alleviates cognitive dysfunction caused by early manganese exposure: Role of catecholaminergic receptors.
    Beaudin SA; Howard S; Santiago N; Strupp BJ; Smith DR
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Apr; 131():110949. PubMed ID: 38266866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensorimotor dysfunction due to developmental manganese exposure is less severe in adult female than male rats and partially improved by acute methylphenidate treatment.
    Beaudin SA; Gorman S; Schilpp N; Woodfin D; Strupp BJ; Smith DR
    Neurotoxicol Teratol; 2024; 102():107330. PubMed ID: 38307398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate alleviates manganese-induced impulsivity but not distractibility.
    Beaudin SA; Strupp BJ; Uribe W; Ysais L; Strawderman M; Smith DR
    Neurotoxicol Teratol; 2017 May; 61():17-28. PubMed ID: 28363668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral methylphenidate alleviates the fine motor dysfunction caused by chronic postnatal manganese exposure in adult rats.
    Beaudin SA; Strupp BJ; Lasley SM; Fornal CA; Mandal S; Smith DR
    Toxicol Sci; 2015 Apr; 144(2):318-27. PubMed ID: 25601986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal choline supplementation lessens the behavioral dysfunction produced by developmental manganese exposure in a rodent model of ADHD.
    Howard SL; Beaudin SA; Strupp BJ; Smith DR
    Neurotoxicol Teratol; 2024; 102():107337. PubMed ID: 38423398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal choline supplementation lessens the behavioral dysfunction produced by developmental manganese exposure in a rodent model of ADHD.
    Howard SL; Beaudin SA; Strupp BJ; Smith DR
    bioRxiv; 2023 Oct; ():. PubMed ID: 37425833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental Manganese Exposure Causes Lasting Attention Deficits Accompanied by Dysregulation of mTOR Signaling and Catecholaminergic Gene Expression in Brain Prefrontal Cortex.
    Santiago NA; He B; Howard SL; Beaudin S; Strupp BJ; Smith DR
    bioRxiv; 2023 Jul; ():. PubMed ID: 37503220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal Models of Childhood Exposure to Lead or Manganese: Evidence for Impaired Attention, Impulse Control, and Affect Regulation and Assessment of Potential Therapies.
    Smith DR; Strupp BJ
    Neurotherapeutics; 2023 Jan; 20(1):3-21. PubMed ID: 36853434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Postnatal Manganese Exposure Causes Lasting Impairment of Selective and Focused Attention and Arousal Regulation in Adult Rats.
    Beaudin SA; Strupp BJ; Strawderman M; Smith DR
    Environ Health Perspect; 2017 Feb; 125(2):230-237. PubMed ID: 27384154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manganese in children with attention-deficit/hyperactivity disorder: relationship with methylphenidate exposure.
    Farias AC; Cunha A; Benko CR; McCracken JT; Costa MT; Farias LG; Cordeiro ML
    J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):113-8. PubMed ID: 20415606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early postnatal manganese exposure causes arousal dysregulation and lasting hypofunctioning of the prefrontal cortex catecholaminergic systems.
    Conley TE; Beaudin SA; Lasley SM; Fornal CA; Hartman J; Uribe W; Khan T; Strupp BJ; Smith DR
    J Neurochem; 2020 Jun; 153(5):631-649. PubMed ID: 31811785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder.
    Tucha O; Prell S; Mecklinger L; Bormann-Kischkel C; Kübber S; Linder M; Walitza S; Lange KW
    Psychopharmacology (Berl); 2006 Apr; 185(3):315-26. PubMed ID: 16521033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate administration reverts attentional inflexibility in adolescent rats submitted to a model of neonatal hypoxia-ischemia: Predictive validity for ADHD study.
    Miguel PM; Deniz BF; Confortim HD; Bronauth LP; de Oliveira BC; Alves MB; Silveira PP; Pereira LO
    Exp Neurol; 2019 May; 315():88-99. PubMed ID: 30771298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate and environmental enrichment ameliorate the deleterious effects of prenatal stress on attention functioning.
    Zubedat S; Aga-Mizrachi S; Cymerblit-Sabba A; Ritter A; Nachmani M; Avital A
    Stress; 2015; 18(3):280-8. PubMed ID: 25783195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early life versus lifelong oral manganese exposure differently impairs skilled forelimb performance in adult rats.
    Beaudin SA; Nisam S; Smith DR
    Neurotoxicol Teratol; 2013; 38():36-45. PubMed ID: 23623961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate improves some but not all measures of attention, as measured by the TEA-Ch in medication-naïve children with ADHD.
    Paton K; Hammond P; Barry E; Fitzgerald M; McNicholas F; Kirley A; Robertson IH; Bellgrove MA; Gill M; Johnson KA
    Child Neuropsychol; 2014; 20(3):303-18. PubMed ID: 23639119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate treatment increases hippocampal BDNF levels but does not improve memory deficits in hypoxic-ischemic rats.
    Miguel PM; Deniz BF; Confortim HD; de Almeida W; Bronauth LP; Vieira MC; Bertoldi K; Siqueira IR; Silveira PP; Pereira LO
    J Psychopharmacol; 2020 Jul; 34(7):750-758. PubMed ID: 32255391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of developmental exposure to methylphenidate on rat brain's immune privilege and behavior: Control versus ADHD model.
    Coelho-Santos V; Cardoso FL; Leitão RA; Fontes-Ribeiro CA; Silva AP
    Brain Behav Immun; 2018 Feb; 68():169-182. PubMed ID: 29061363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.